Brinter

Brinter is a bioprinting company that develops and manufactures 3D bioprinters, bioinks, and related hardware for customers in the pharmaceutical, biotech, research, and cosmetics sectors. The company's flagship product is the Brinter One, a multi-material deposition-based 3D bioprinter capable of working with both stiff and soft cell-laden hydrogels. In March 2022, Brinter launched the Brinter Core, an entry-level model aimed at making bioprinting more accessible.

Brinter's technology revolves around the ability to precisely deposit biomaterials like living cells and natural or synthetic hydrogels in layers to create 3D structures. The company's bioprinters can combine multiple bioinks and create gradients within printed structures, enabling the development of personalized drugs and functionalized materials for applications such as tissue regeneration and targeted cancer treatments.

Originally established as a 3D printing company in Finland, Brinter transitioned its focus to cartilage applications and aims to disrupt the orthopedic implant market through personalized tissue therapeutics. The company is currently developing 3D bioprinted personalized meniscus cartilage implants for knee surgeries, with the goal of providing orthopedic patients with longer-lasting, biologically matched knee repairs. Brinter's approach involves using the patient's own cellular material to create bioinks, potentially reducing rejection rates.

In December 2022, Brinter launched what it claimed to be the world's first multi-material, multi-fluidic bioprinting printhead, capable of printing up to 4,096 different material combinations in a single build. This advanced printhead expands the company's range of potential applications and enables greater precision in deposition.

Brinter has bootstrapped its growth since its inception and launched its first commercial product in 2020. As of June 2023, the company is active in over ten countries, including the US, Germany, the UK, and India, with clients such as Bayer, PerkinElmer, Nanoform, and various research organizations.